The company received $190.


23andMe’s research team will also search for previously unknown genetic factors associated with response to these classes of medicines, taking into consideration a broad range of nongenetic factors such as age group, sex, and body-mass index, amongst others. Related StoriesNew clinical trial on breast malignancy may help treat and control diseaseGenetic reduction of AMPK enzyme can prevent or delay hearing lossMoffitt Tumor Center study finds hyperlink between common gene mutations and tumor immune surveillanceIn earlier studies, 23andMe provides demonstrated that self-reported information from customers yields data of quality much like that gathered using traditional research methods. Additional benefits of 23andMe’s web-based study model include: the capability to perform hundreds of research in parallel; easy and effective methods to contact individual individuals multiple times and have follow-up questions – – this permits 23andMe experts to quickly zero-in on associations that could be the inspiration for future research aimed at prevention, better remedies, and cures for a variety of diseases and circumstances potentially.Michael’s Medical center. Patients with acute kidney disease are a high-risk group for whom early medical surveillance and intervention may prevent progression to irreversible end-stage kidney disease. Approximately two million Canadians have kidney disease and more than 20,000 of these people receive ongoing chronic dialysis, based on the Kidney Foundation of Canada. Related StoriesBoston Kids's Medical center selects Vijay G. Sankaran to get Rising Star AwardGlan Clwyd Medical center N Wales invest in Esaote's G-Scan MRI unit for weight-bearing scanningPatients offered animal-assisted therapy at UCLA HealthThe research, published in the September 16 issue of the Journal of the American Medical Association , is the largest study to date to check out the long-term health implications for patients who have experienced acute kidney injury.